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The notion that electrophiles serve as messengers in cell signaling is now widely accepted. Nonetheless,
major issues restrain acceptance of redox homeostasis and redox signaling as components of main-
tenance of a normal physiological steady state. The ﬁrst is that redox signaling requires sudden switching
on of oxidant production and bypassing of antioxidant mechanisms rather than a continuous process
that, like other signaling mechanisms, can be smoothly turned up or down. The second is the mis-
perception that reactions in redox signaling involve “reactive oxygen species” rather than reaction of
speciﬁc electrophiles with speciﬁc protein thiolates. The third is that hormesis provides protection
against oxidants by increasing cellular defense or repair mechanisms rather than by speciﬁcally ad-
dressing the offset of redox homeostasis. Instead, we propose that both oxidant and antioxidant signaling
are main features of redox homeostasis. As the redox shift is rapidly reversed by feedback reactions,
homeostasis is maintained by continuous signaling for production and elimination of electrophiles and
nucleophiles. Redox homeostasis, which is the maintenance of nucleophilic tone, accounts for a healthy
physiological steady state. Electrophiles and nucleophiles are not intrinsically harmful or protective, and
redox homeostasis is an essential feature of both the response to challenges and subsequent feedback.
While the balance between oxidants and nucleophiles is preserved in redox homeostasis, oxidative stress
provokes the establishment of a new radically altered redox steady state. The popular belief that
scavenging free radicals by antioxidants has a beneﬁcial effect is wishful thinking. We propose, instead,
that continuous feedback preserves nucleophilic tone and that this is supported by redox active nutri-
tional phytochemicals. These nonessential compounds, by activating Nrf2, mimic the effect of en-
dogenously produced electrophiles (parahormesis). In summary, while hormesis, although globally
protective, results in setting up of a new phenotype, parahormesis contributes to health by favoring
maintenance of homeostasis.
& 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. The Golden Mean: the ethics of redox homeostasis
In the 19th Century Claude Bernard pointed out the relevance
of the maintenance of the milieu intérieur we know today as
homeostasis, as the crucial element of a healthy status. Con-
sistently, the loss of homeostasis gives rise to a different status we
recognize as disease. Maintaining or reestablishing homeostasis is
therefore, the way of preventing disease and curing it.
Relevant evidence supporting the view of Claude Bernard
emerges today from the modern view of inﬂammation and redox
signaling. When presented with a challenge, an integrated biolo-
gical system reacts to eliminate the challenge and prevent damage.
For this purpose, oxidants that act as signaling species are in-
creased from their steady state rate of production and elimination.
The upturn of redox signaling increases both pro-inﬂammatoryB.V. This is an open access article ucytokines and pro-oxidant enzymes. Eventually, a feedback me-
chanism returns this “reactive” condition to the physiological
range of oxidant production. However, when the overall attempt
to reestablish the pre-challenge nucleophilic tone is inadequate,
we recognize the new condition as an “inﬂammatory disease.”
In philosophical terms, this pro/anti inﬂammation balance is
reminiscent of the epicurean philosophy where the aurea medio-
critas, the Golden Mean, is the best way to optimize the quality of
life, maintaining the equilibrium among motivations pushing our
behavior in opposite directions. The “good” is not necessarily to-
ward a single direction. Therefore, the condition of tranquility
(ἀταραξία) as described in the epicurean philosophy, is obtained
by mitigating what would overwhelmingly push our behavior in
either direction. This is not only the ethical way to reach an op-
timized quality of life, but also emerges as a major mechanism for
protection of our health. We must be able to react to challenges,
but never too much. Excess in either direction perturbs thender the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. The “Golden Mean” of redox homeostasis. A steady-state redox status of the ensemble of redox couples is maintained by metabolic ﬂuxes and redox feedback where
electrophiles produced by aerobic life stressors activate the mechanism reestablishing nucleophilic tone. Parahormesis refers to nonessential compounds that support the
redox feedback loop activating the nucleophilic response. As long as homeostasis is maintained, there is not a phenotypic switch. In contrast, a phenotypic switch occurs in
adaptation when a stable offset of homeostasis takes place. In the scheme two opposing examples of stable offset of redox homeostasis are illustrated; one refers to a more
oxidizing environment (e.g. oxidative stress) facilitating cell death, while the other refers to a dramatically more reducing environment (e.g., constitutive activation of Nrf2),
facilitating survival. Both conditions are part of pathological phenotypes.
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the Golden Mean of the ethical philosophers. The concept of the
Golden Mean in redox homeostasis, proposed and discussed in
this article is summarized in Fig. 1.2. When a challenge evolves to stress
The notion of stress was introduced in a biological context by
Hans Selye to describe the inappropriate physiological response to
a demand [1]. Under physiological conditions, different challenges
(physical, chemical or biological) prime a response that pushes the
cellular homeostasis toward the oxidative boundary of the steady
state range [2] and is usually countered by a feedback reaction [3]
addressed to diminish the response and restore homeostasis to-
ward the mean. If the stimulus persists or the feedback response is
inadequate (in quantitative or qualitative terms) the result is a
permanent alteration of homeostasis. In the framework of redox
biology, challenges that increase production of oxidants are part of
innate immunity increasing elementary pro-inﬂammatory reac-
tions, but not necessarily resulting in inﬂammation. Notably, these
electrophiles also upregulate feedback nucleophilic responses to
restore the original steady state. The notion of oxidative stress, as
originally proposed, denoted a stable alteration of redox home-
ostasis [4]. Putting this in terms of what we deﬁne here as redox
homeostasis, oxidative stress occurs only when the boundary of
the physiologic redox steady state is breached.
Aerobic life, exposure to xenobiotics (food, drugs and poisons)
and interaction with other living systems are potentially damaging
events that directly or indirectly challenge redox homeostasis. The
capacity to deal with these challenges is indispensable for life [5].
In the majority of reports on pathological conditions in which
oxidative stress is seen as an underlying mechanism, it is proposed
that when pro-oxidative/pro-inﬂammatory pathways are turned
on, biological damage is produced only when antioxidant capacity
is overwhelmed. This disregards the fact that electrophiles and
nucleophiles are both primary players in redox signaling and that
signal transduction takes place through the ﬁne adjustment of a
rheostat rather than by the ﬂipping of an on–off switch. Organismsrespond to different challenges by increasing both oxidative re-
actions and nucleophilic feedback in order to prevent a stable
offset of redox homeostasis. Thus, while redox homeostasis is
maintained by continuous signaling for the production and elim-
ination of electrophiles and nucleophiles [6] a pathological status
is generated either by: i) a permanent harmful challenge, or ii) an
inappropriate response to injury, or iii) an inefﬁcient nucleophilic
feedback leading to stable displacement from the basal redox
steady state.
As stress is the inability to deal with a challenge, oxidative
stress describes the consequence of the failure to maintain the
physiological redox steady state, which is the self-correcting
physiological response to different challenges. Adaptive hormesis
[7] is different from the maintenance of homeostasis. Typically,
mild stimuli, potentially harmful when the exposure is larger in
time and concentration, prime a phenotypic shift that brings
protection against the same stimulus. Maintenance of redox
homeostasis and adaptation may use some of the same signaling
pathways; however, the crucial difference is that adaptation es-
tablishes a new homeostatic setting that provides some protection
but is necessarily associated with a permanent modiﬁcation of a
function, which may be more or less severe. Adaptation to 100%
O2, is a classic example of this. Exposure of mammals to 100% O2
kills within a few days by causing lung cell death and pulmonary
edema [8,9]. Young adult rats and some other rodents, when very
young, can adapt to breathing 100% O2 by being exposed to 85–
90% O2 for several days before exposure to 100% O2 [10]. The
adaptive mechanisms (hormetic) include the induction of anti-
oxidant and repair enzymes [9,10]. But there is also signiﬁcant
alteration of lung structure so that animals returned to air resolve
into permanently altered lungs, mimicking emphysema with its
loss of alveoli and scarring [11]. Thus, the effect of 85% O2 allows
exposure to 100% O2, but saying, according to the concept of
hormesis, that the rodent is “stronger,” is debatable.
The redox state as deﬁned from the redox potential of a speciﬁc
redox couple, as in the popular Nernst equation for GSH and GSSG,
is misleading. The equation provides a mathematical result related
to the thermodynamics of the reaction, but not to the biological
condition we aim to describe as redox state. What is relevant is
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means the ratio between the concentration of the reduced and the
oxidized form. The actual concentrations of GSH and GSSG are
generated from the rates of GSH oxidation by several hydroper-
oxides, GSSG reduction by NADPH, GSH conjugation to electro-
philes, GSH and GSSG use in protein folding, export and import of
GSH, GSSG and conjugates, synthesis of GSH, and import and
synthesis of its constituent amino acids, particularly cys, as well as
the scavenger pathway in which gamma-glutamyl transferase uses
cystine to bypass glutamate cysteine ligase. Then there are the
rates of synthesis, degradation and regulation of the activities of
all the enzymes and transporters. Thus, the redox steady state is
dependent on concentrations and kinetic rate constants for mul-
tiple reactions and is in constant ﬂux. In other words, quantiﬁca-
tion of physiological redox homeostasis may entail determination
of normal ranges of several major electrophiles and nucleophiles
in a manner similar to the way we now determine normal phy-
siological ranges for plasma glucose.3. What drives redox homeostasis from the oxidizing side?
Sources of electrophiles: aerobic life, generation of oxidizing
molecules in water and lipid phase
Superoxide and H2O2 are continuously produced during aerobic
metabolism. It was once thought that ·−O2 was only produced by
the phagocytic cell NADPH oxidase (Nox2) in response against
microbes [12], by leaks from the mitochondrial electron chain
[13,14], by some ﬂavoprotein oxidases [15,16], and the autoxida-
tion of some small molecules and iron proteins [17–19]. With the
exception of the phagocytic killing of microbes, the other pro-
duction was considered an unfortunate consequence of living with
oxygen. But, for the past two decades, intentional formation of
H2O2 has been recognized as a component of intracellular signal
transduction.
H2O2 production by cells varies markedly in terms of both
amount and duration between what is required for cell signaling
versus what is needed to kill a microbe. But, it must be noted that
H2O2 production is never actually turned off and that its produc-
tion is highly regulated as part of redox homeostasis. While su-
peroxide is continuously produced, a variety of stimuli can pro-
voke a marked increase in its generation. Following the discovery
that Nox2 was one of several related Nox proteins that could
generate superoxide [20–22], it was realized that signaling sti-
mulated by a variety of agonists, challenges and stressors such as
growth factors, hormones and shear forces, depended on in-
creased superoxide production by Nox proteins [22–26].
Mitochondria are a continuous source of H2O2. The production
of H2O2 is actually a result of the removal of ·−O2 by superoxide
dismutase formed by the thermodynamically unfavorable oxida-
tion of ubisemiquinone [27]. Functionally, H2O2 generation is ac-
celerated when respiratory chain cytochromes are fully reduced
(state 4 respiration) [28]. This is the condition of replenishment of
metabolic energy (low ADP/ATP ratio) and overabundance of oxi-
dizable substrates. This condition is well described by the concept
of nutrient overload and mitochondrial gridlock typical of meta-
bolic syndrome associated with type II diabetes [29].
Linked to the notion of potentially risky production of oxidants
by the respiratory chain in state 4, mild uncoupling of respiratory
chain can be seen as an indirect antioxidant mechanism as it in-
creases the ﬂow of electrons toward cytochrome oxidase while
decreasing the electron transfer from ubisemiquinone to oxygen.
Indeed, it appears that a minor uncoupling may be beneﬁcial
[30,31]. All of this is physiologically relevant and recent work
suggests that mitochondrial superoxide/H2O2 production is part of
redox homeostasis as well as a response to stress [32–34]. This is arather relevant area needing further in depth investigation.
Lipid peroxidation is a chain of reactions producing in mem-
branes lipid hydroperoxides (LOOH) and their degradation pro-
ducts. It is initiated by the formation of a carbon centered radical
in a polyunsaturated fatty acid of a complex lipid [35,36]. Upon
oxygen addition, the formed lipid hydroperoxyl radical initiates
the propagation phase when carbon centered radicals and LOOH
are continuously produced in the chain reactions. The length of
the chain depends on nature of the membrane and the presence of
the chain breaking antioxidant α-tocopherol. The most relevant
mechanism of initiation is the hydrogen abstraction by a lipid al-
koxy radical, in turn produced by breakdown of the O–O bond of a
LOOH. This indicates that the crucial players of initiation are a
transition metal and a preexisting LOOH. Notably, a unique and
speciﬁc mechanism of the formation of initial traces of hydroper-
oxide derivatives of polyunsaturated fatty acids is not known with
certainty. Nevertheless, there is no doubt that lipid peroxidation
requires decomposition of LOOH. Consistently, the continuous re-
duction of LOOH by the selenoenzyme phospholipid hydroper-
oxide glutathione peroxidase (PHGPx, also known as GPx4) [37] is
by far the most relevant anti-peroxidative mechanism.
In addition, lipoxygenases that catalyze production of LOOH
require activation by hydroperoxides [38]. Indeed, in the presence
of GPx4 and GSH, 15-lipoxygenase is inactive [39]. Lipophilic
electrophiles are produced from hydroperoxides of poly-
unsaturated fatty acids (see [40] for recent review). The notion
that all these species are produced only from free fatty acids re-
leased by a phospholipase has been recently challenged by the
evidence that oxidized fatty acids can also be enzymatically pro-
duced in intact phospholipids [41,42]. This concept speciﬁcally
addresses the issue of redox signaling supported by lipid oxidation
in the membrane compartment. It should also be noted that li-
poxygenases as well as cyclooxygenases are probably never com-
pletely inactive, as suggested by the three decade-old “peroxide
tone” concept of Lands [38,43]. Indeed, peroxide tone is an integral
part of redox homeostasis.
Among the major products of lipid peroxidation generated
when LOOH are decomposed, some deserve special mention. The
most relevant are α,β-unsaturated aldehydes, one of which 4-hy-
droxy-2-nonenal (HNE) is major product of decomposition of hy-
droperoxides of n-6 fatty acids. HNE apparently fulﬁlls the re-
quisites for being considered a signal transducing species [44–46].
While usually associated with oxidative stress, which dramatically
elevates HNE production [47,48], normal plasma contains 0.1–
1.4 μM HNE [49], which is sufﬁcient to maintain signaling for the
production of steady state mRNA expression of enzymes active in
maintaining the nucleophilic tone [50]. Notably, it has been re-
cently reported that HNE is not only a major product of non-en-
zymatic lipid peroxidation [45], but can also be formed by a spe-
ciﬁc mechanism at the active site of a lipoxygenase [46]. Lipid
peroxidation has been recently discovered as the underlying me-
chanism of a caspase independent cell death subroutine requiring
free iron, named ferroptosis. Consistently, silencing of GPx4 or
decreasing GSH invariably leads to cell death [51,52].
Electrophiles, either soluble or lipophilic, act through post
translational modiﬁcations (PTM) where the rate of conjugation
with an amino acid residue depends largely on the nucleophilic
reactivity of the target, with a cysteine in the thiolate (S-) form
being markedly more reactive than lysine or histidine [53]. There
is also a rank order of reactivity of different thiolate residues. The
kinetic constraints for the oxidation/alkylation of different thiolate
residues include having a low pKa, protonation of the leaving
group and, obviously, the steric feasibility of the bimolecular in-
teraction [54]. When disulﬁdes are formed, the thermodynamics
of the thiol disulﬁde redox couple also permits a distinction be-
tween low potential couples (relatively more resistant to
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couples (relatively easier to reduce), likely serving as the reversible
redox coupling switches in signal transduction pathways [55].
In summary, the reduction of hydroperoxides is the crucial
reaction controlling the steady state concentration of electrophiles
continuously produced and, when appropriate, involved in sig-
naling. This nicely ﬁts the observation that silencing GPx1 or GPx4
produces an oxidizing environment speciﬁcally in the cytosol or
membrane, respectively [56], and this deeply affects the
phenotype.4. What drives redox homeostasis from the reducing side?
Sources of nucleophiles: Nrf2 and the nucleophilic tone
As outlined above, the formation of electrophiles is con-
tinuously countered by a feedback nucleophilic response, indis-
pensable for maintaining redox homeostasis. Nrf2, also called NF-
E2-related factor 2, is the master regulator for increasing genes
that code for enzymes protecting cells from electrophilic stress.
Thus, in non-stressed cells Nrf2 is relatively less active in co-
ordination with the basal ﬂow of endogenously generated elec-
trophiles. The increased oxidative activation of Nrf2 accounts for
both the enhanced synthesis of nucleophiles such as GSH and Trx
and the enzymes catalyzing the redox transitions. Increased ac-
tivity hey of the pentose phosphate shunt contributes to the in-
crease of the nucleophilic tone by supplying the NADPH required
for the continuous reduction of the disulﬁde forms of glutathione
and Trx.
As we recently reviewed the history of the discovery of Nrf2
and Keap1, the regulator of Nrf2 and the actual sensor of electro-
philes [6] and a whole volume on Nrf2 regulation has recently
been co-edited by one of us [57], we will only very brieﬂy describeFig. 2. Electrophilic activation of Nrf2. When cysteines in Keap1 are modiﬁed by electr
degradation and can translocate to the nucleus [133–135]. Phosphorylation of Nrf2 by
scription of genes through binding to the EpRE (also called ARE) element [136,137]. PKC
The proteins that are Nrf2 partners in binding to EpRE include Mafs G/F/K [143], c-Jun [1
paid to whether any of their interactions with Nrf2 involve redox signaling. Similarly, lit
that compete with Nrf2 for binding to EpRE [149]. Furthermore, potential redox regul
acceleration of Nrf2 degradation [150] and the stabilizing inﬂuence of p21 [151] have ye
involved with Nrf2. Additional redox-related activation of Nrf2 may occur during stre
dysregulation of autophagy [152].the principal signaling pathways through which electrophiles ac-
tivate Nrf2 (Fig. 2). It should however, be noted that H2O2 is a less
efﬁcient activator of Nrf2 in comparison with thiol-conjugating
electrophiles (reviewed in [6]). Thus, redox homeostasis reﬂects
more the state of electrophile production, seemingly produced by
lipid peroxidation, than the ﬂux of H2O2.
During a long lasting inﬂammatory response to a persistent
stressor, these same signaling pathways are used to attempt to
restore redox homeostasis, but the adjustment results instead in
the establishment of a new redox steady state. Notably, Nrf2 also
activates two pathways eventually leading to an increased pro-
duction of electrophiles. Heme oxygenase, expressed under con-
trol of Nrf2, releases iron [58]. Furthermore, the multidrug re-
sistance protein, also under control of Nrf2, exports GSH [59]. This
condition, in sensitive cancer, sensitizes cells to ferroptosis [60],
the peculiar form of programmed cell death controlled by GPx4
[61] which relies on lipid peroxidation [62]. Activation of ferrop-
tosis emerges today as a promising target for cancer chemotherapy
and recent evidence indicates that p53 modulates cysteine avail-
ability for GSH synthesis and controls, seemingly through the
same basic mechanism, oncosuppression and organismal home-
ostasis [63,64]. Far from being paradoxical, these effects of Nrf2
leading to a decrease of the nucleophilic tone, highlight the re-
levance of the ﬁne tuning of the redox steady state, operating by
multiple enzymatic activities and feedback regulation. In addition,
the Nrf2 related transcription factor, Nrf1, may have a role in redox
homeostasis, which has not been generally recognized [65]. In
transcriptional control of some genes, Nrf1 isoforms may compe-
titively inhibit, substitute, or surpass Nrf2 activation of EpRE [66].
Intriguingly, Nrf1 is apparently essential during development,
while Nrf2 is not [67], yet Nrf2 knockout is clearly the principle
transcription factor that responds to increases in electrophiles
[68].ophiles, Nrf2 escapes Keap1 assisted ubiquitinylation and subsequent proteasomal
PKCδ and Akt assists in the nuclear translocation of Nrf2, where it increases tran-
δ, and Akt are also activated by hydroperoxides and other electrophiles [138–142].
44], c-Fos and Fra1 [145], c-Maf [146], JunD [147,148], but little attention has been
tle attention has been paid to the possibility of redox regulation of Bach1 and Nrf1
ation of c-Myc inhibition of transcription through its binding to nuclear Nrf2 and
t to be explored in detail. All of these aspects may be part of the redox homeostasis
ss conditions through the sequestration of Keap1 by p62 such as occurs during
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The increased in NF-κB activity is often considered as a sudden
turning on of signaling for this essential transcription factor. But,
as can be seen by simple observation in controls of nuclear NF-κB
and positive bands in electrophoretic mobility shift assays, NF-κB
is actually always “on” to some degree. Thus, turning up and down
of NF-kB activity is an essential component of maintenance of
redox homeostasis rather than a beginning and end of in-
ﬂammation. Nonetheless, as for many cases in signaling, the ten-
dency is to refer to upturn as activation. Schreck et al. [69] ﬁrst
demonstrated that NF-κB could be increased in cells by addition of
exogenous H2O2. Increases in NF-κB activity caused by en-
dogenous production of H2O2 was demonstrated a few years later
[70], although it was thought at that time that only phagocytes
produced H2O2 upon stimulation of their NADPH oxidase (now
called Nox2).
Multiple pathways (canonical (classical), non-canonical, and
atypical) lead to NF-κB activation, but not all have been suggested
to be redox regulated [71,72]. We have not attempted to be
comprehensive but rather focus on some potential targets and
mechanism of action of oxidative regulation, particularly those
that would likely occur during maintenance of redox homeostasis.
Fig. 3 shows the activation of NF-κB by H2O2. This follows several
pathways that differ among cell types [3] so that there is no one
pathway that can be assumed to be involved in NF-κB activation
without investigation. The mechanisms in Fig. 3 represent the
likely signaling that occurs as part of redox homeostasis. In con-
trast, Fig. 4 represents the signaling pathway for NF-κB activation
that occurs during stimulation of macrophages by iron-laden silicaFig. 3. Hydroperoxide activation of NF-κB activation. NF-κB is composed of homo- and h
transcriptional activation domains. IκB family members bind NF-κB dimers in the cytoso
dependence upon the IKK complex for their phosphorylation. Two serine kinases, IKKα
phosphorylates IκB. For an extensive description of NF-κB regulation not focusing on red
investigation of how H2O2 activated NF-κB, it became obvious that tyrosine phosphory
oxidation products, can directly activate members of the Src kinase family, Src, Syk, and
serine kinase PKCδ that activate PKD. In an alternative pathway, Src or Syk directly ph
intriguing proposed targets in H2O2 activation of NF-κB is SHIP-1, an inositol-5-phosph
classical IKK-dependent pathway for NF-κB activation. SHIP-1 activity depends on its SH
study unrelated to NF-κB activation, SHIP-1 activity was demonstrated to be through it
Other possible pathways for NF-κB activation involving the Src kinases may exist; howe
studies suggest H2O2 activates NF-κB. Although it is not clear exactly how and where NF
ability of NF-κB to bind to DNA in the nucleus [156].particles [73,74]. The non-oxidative part of this pathway can also
be stimulated by lipopolysaccharide [75,76].
While there are some cases in signal transduction where H2O2
is clearly the molecule involved, it must be stated that the actual
molecule that interacts with the target in many other cases may
not be H2O2 itself but rather a LOOH [77,78]. There are also reports
that hypochlorous acid and singlet oxygen can activate NF-κB and
that peroxynitrite can either activate or inhibit NF-κB. Notably,
dietary electrophilic isocyanates inhibit NF-κB activation [79–81]
while HNE, an endogenous electrophile appears to directly in-
activate NF-κB [82]. Thus, HNE does not appear to activate NF-κB
under conditions where it forms adducts with other proteins
leading to JNK activation [83,84]. NF-κB activation therefore ap-
pears to discriminate between hydroperoxides and other
electrophiles.6. Oxidative signaling in JNK/AP-1 pathway
Similarly to NF-κB, activation of the mitogen activated protein
kinases, Jun N-terminal kinase (JNK) was originally thought to be
an on/off response, in this case to stress. Indeed, JNK was also
called SAPK for stress activated protein kinase. But, JNK is now
well established as both a key player in cell survival or death, and
as essential to regulation of metabolism and cell proliferation [85].
Thus, as with NF-κB, its “activation” is really a turning up rather
than a turning on.
Increased JNK activity, increases phosphorylation and activity
of the AP-1 transcription factor. This can be achieved by both hy-
droperoxides and HNE (Fig. 5). Ichijo and coworkers [86,87] usingeterodimers of p50, p52, p65 (RelA), c-Rel, and RelB. Only p65, c-Rel, and RelB have
l until IκB is phosphorylated and degraded. IκB isoforms differ among cell types in
and IKKβ, and a modulator, NEMO (also called IKKγ) form the IKK complex that
ox regulation, the reader is referred to some recent reviews [153,154]. Early in the
lation was involved. H2O2, lipid hydroperoxides, and other electrophilic lipid per-
Lyc and the closely related ZAP leading to activation of the tyrosine kinase Abl and
osphorylate IκB on a tyrosine residue, bypassing IKK activation. One of the more
atase. SHIP-1 activation by H2O2 has been shown to lead to the activation of the
2 domain, which is of course, the classic target of tyrosine phosphorylation and in a
s tyrosine phosphorylation by Lyn, another member of the Src kinase family [155].
ver, the activation of the Src kinases seems to be the key step through which most
-κB is oxidized, the redox chaperone activity of APE/Ref-1 is required to restore the
Fig. 4. Activation of NF-κB-dependent cytokine production through lipid peroxidation. When non-cytotoxic levels of iron-laden particles interact with macrophages, the
resulting lipid peroxidation in the area of the plasma membrane with which the particle interacts, produces a stress response that activates NF-κB and pro-inﬂammatory
cytokine production. Lipid raft disruption caused by minor lipid peroxidation, results in the release of calcium from annexin 6 leading to the activation of phosphati-
dylcholine speciﬁc phospholipase C (PC-PLC) activation that produces diacylglycerol (DAG). DAG then activates acidic sphingomyelinase (ASM) that produces ceramide.
Ceramide then activates ceramide-activated protein kinase (CAPK), which phosphorylates IκB allowing NF-κB to migrate to the nucleus. The PC-PLC-dependent pathway can
also be stimulated by endotoxin, again representing a non-physiological stress response [75,76].
F. Ursini et al. / Redox Biology 8 (2016) 205–215210exogenous H2O2, suggested that the mechanism of H2O2 activation
of JNK was dissociation of thioredoxin (Trx) bound to the ASK1
(apoptosis signaling kinase 1) when that Trx was oxidized. Sub-
sequently, the ability of endogenously generated H2O2 to activate
the pathway from dissociation of Trx from ASK1 to c-Jun phos-
phorylation by JNK was demonstrated [88] and then shown to be
dependent upon peroxiredoxin 1 (Prdx1) [89].
An increase in JNK activity by HNE was shown initially to occur
as a direct result of HNE binding to JNK [84]. JNK activity could beFig. 5. Redox activation of JNK/AP-1. H2O2 activates JNK through the Prdx1 catalyzed ox
dimerize and phosphorylate the dual speciﬁcity (ser/thr and tyr phosphorylating) mitog
or JNK2. JNK then phosphorylates the c-Jun transcription factor, which pairs with anothe
that binds to the TRE element of many AP-1-regulated genes. As with NF-κB (Fig. 3), AP-1
Ref-1 to bind to DNA [156,157].increased through inhibition of the upstream protein tyrosine
phosphatase, SHP-1 [90] with pathways differing in cell types.7. Oxidative signaling in PTEN/PI3K/Akt pathway
During physiological signaling stimulated by a variety of ago-
nists, phosphatidylinositol phosphorylation in cell membranes is
increased by PI3K (phosphatidylinositol 3 kinase) to increaseidation of Trx bound to ASK1. The Trx dissociates from ASK1, allowing the kinase to
en activated kinase kinase, MKK4. MKK4 in turn phosphorylates and activates JNK1
r member (X) of the Jun/Fos family of transcription factors forming an AP-1 complex
appears to require reduction in the nucleus by the redox chaperone activity of APE/
F. Ursini et al. / Redox Biology 8 (2016) 205–215 211phosphatidylinositol 3-phosphate (PI(3)P), phosphatidylinositol
(3,4)-bisphosphate (PI(3,4)P2), and phosphatidylinositol (3,4,5)-
trisphosphate (PI(3,4,5)P3 or PIP3). The increased formation of PIP3
allows several enzymes to increase their binding to the membrane
where they are active. One of these PIP3-regulated enzymes is
PDK1, the protein kinase that phosphorylates and activates Akt
(also known as PKB), a key protein kinase that activates mTOR,
IKKα, which activates NF-κB by phosphorylating IκB (Fig. 3), and a
variety of other signaling kinases. Akt activity is essential in de-
velopment and aberrations in it result in several pathologies [91].
PTEN (phosphatase and tensin homolog) is a phosphatase that
removes a phosphate from PIP3 (phosphatidylinositol (3,4,5)-tri-
sphosphate) to produce PIP2 (phosphatidylinositol (4,5)-bispho-
sphate), which does not bind and activate the PIP3-regulated en-
zymes. Importantly, PTEN is normally active in unstimulated cells.
So, decreasing PTEN activity is critical in permitting increased
activity of PIP3-dependent enzymes. One of the ﬁrst signaling
pathways to be demonstrated to have a direct interaction with
H2O2 was the reversible inactivation of PTEN by Rhee and cow-
orkers [92]. Later, it was shown that stimulation of endogenous
transient H2O2 production could increase the resting level of PTEN
glutathionylation and Akt activation [93]. Transient PTEN in-
activation by glutathionylation is therefore a major player in reg-
ulating redox signaling that is homeostatic. In contrast, prolonged
inactivation of PTEN allows signaling to go into the stress adaptive
mode. As loss of PTEN activity is frequently found in cancers, this
functional loss has become the target of recent therapeutic an-
ticancer therapies [94]. Again, it should be noted that signaling
through the PTEN/PI3K/Akt pathway does not usually involve a
sudden turning on or off, but a rheostatic control of the activities
of these important signaling enzymes.8. Redox homeostasis and nutrition: from the postprandial
oxidative stress to metabolic syndrome
To examine our proposal that everyday life generates chal-
lenges that increase oxidative pro-inﬂammatory pathways and
evolve to stress only when not optimally counteracted by a feed-
back nucleophilic response, we will examine the impact of nutri-
tion. The intake and oxidative metabolism of energetic substrates
actually result in a transient oxidative challenge. The long lasting
effect of chronic excessive caloric intake is obesity, often evolving
to metabolic syndrome and eventually non-alcoholic fatty liver
disease (NAFLD) [95,96]. An alteration of redox homeostasis as-
sociated with chronic inﬂammation emerges today as a common
motif of these pathological conditions.
Energy metabolism generates electrophiles that are expected to
have an impact on cellular nucleophilic tone. Indeed, the response
to glucose of physiological levels of insulin involves both Nox2 and
Nox4. Notably, increased activation of Nox2 and increased tran-
scription of Nox4 by insulin are similar to what is seen with
transforming growth factor-β [25,97] although the signaling
pathway for insulin to activation of Nox proteins has not been fully
elucidated [98–102].
Saturated free fatty acids trigger hepatic inﬂammation via Toll
receptors [103] and NF-κB [104]. Increased availability of sub-
strates of the respiratory chain primes production of superoxide/
hydrogen peroxide in mitochondria. Finally, the excess of substrate
availability in mitochondria eventually leads to synthesis of com-
plex lipids and cholesterol, hyperlipidemia, fatty liver, and obesity
[29]. Obesity, is associated with adipose tissue inﬂammation [2]
contributing to glucose resistance [95] and NAFLD. In this respect,
adipose tissue cytokines by activating NF-κB and an inﬂammatory
response in the liver, contribute to the depression of the nucleo-
philic tone brought by oxidants produced by substrate-loadedmitochondria.
The stimulus for enhanced protein synthesis, primed by ana-
bolic stimuli, evolves into ER stress when protein folding capacity
is exhausted. ER stress [105] produces more oxidants and activates
JNK, which in turn further exacerbates inﬂammation via NF-κB
activation [106]. mTOR [107], activated by excess of nutrients,
stimulates (via JNK) the Unfolded Protein Response (UPR) [108],
which dampens cell sensitivity to insulin [109] and protein
synthesis, concomitantly activating an antioxidant response [108].
In this respect, the UPR and decreased insulin signaling, due to IRS
phosphorylation by JNK or 6SK1, can be seen as adaptive me-
chanisms that provide some immediate protection but contribute
in the long run to stabilize a metabolic offset. This long-lasting
activation is distinctly associated with an increased occurrence of
liver and cardiovascular diseases [96], the leitmotif seemingly
being the less nucleophilic cellular environment [110].
The mTOR pathway coordinates cell growth with availability of
energetic nutrients. While its increased activity and downstream
effects are primed by oxidation (seemingly descending from en-
ergy metabolism and insulin signaling) [111], reduction is ex-
pected to mimic the nutrient deprivation condition. The oxidative
activation of mTOR is seen as an adaptive mechanism counter-
acting ER stress. This, increases UPR [112], but although that pro-
vides protection under emergency conditions, prolonged un-
coupling eventually evolves toward metabolic disorder. The
emerging leitmotif is that the excessive insulin signaling together
with a large availability of energetic substrates decreases the
steady state nucleophilic tone. This impacts, through electrophiles,
on feedback nucleophilic reactions. Pathology seemingly emerges
when homeostasis is compromised and a new more oxidized re-
dox steady state is reached. Supporting the nucleophilic tone by
enzymatic reactions producing an increase in nucleophiles and the
supply of electrons from NADPH is seemingly a major mechanism
for maintenance of physiological homeostasis and thus health.
The condition of increased global energetic substrate avail-
ability inhibits AMPK [113] and sirtuins [114], the regulators of
metabolic control of the fasting condition, while decreased nu-
cleophilic tone also activates mTOR [115] as a typical metabolic
adaptive reaction. These regulatory mechanisms, and the preced-
ing examples of redox regulation of normal metabolism and how
their dysregulation leads to pathological disorders (obesity meta-
bolic syndrome and NAFLD) demonstrate the importance of
maintaining redox homeostasis controlled by the ﬁne tuning of
rheostats rather than the sudden switching on or off of signaling
reactions. This also points out the physiological relevance of
compounds we consume with nutrition, which are not nu-
tritionally essential, but largely contribute to health by supporting
nucleophilic tone in cooperation with the endogenous players of
redox feedback, which we address further below.9. Nucleophilic tone and cancer
A challenging paradox has recently appeared in publications
concerning redox reactions and signaling in cancer. While a more
oxidizing environment sustained by electrophiles increases the
risk of carcinogenesis [116,117], the uncontrolled activation of the
pathways increasing the nucleophilic response favors malignancy
and the metastatic spread of cancer cells [118]. The solution of this
conundrum is the critical analysis of the context [119] to which our
concept of homeostatic regulation of nucleophilic tone brings a
substantial contribution. The major hallmarks of epithelial cancers
(proliferation, survival, angiogenesis, EMT, escape from anoikis)
are activated by oxidative redox transition [120]. In this respect,
oxidative inﬂammation is a pro cancer event and the reestablish-
ment of the nucleophilic tone is protective. On the other hand, in
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that Nrf2 is more longer lived and more abundant, producing a
phenotype that provides a biological advantage for fast pro-
liferating cells [121]. This phenotypic shift abolishes the normal
rheostatic regulation of nucleophilic tone. In these cells, the ad-
dition of N-acetylcysteine and vitamin E further prevents the ex-
ecution of cell death and leading to a more malignant invasive
phenotype. Far from being paradoxical, this evidence further
supports our notion of the importance of maintaining the “Golden
Mean,” with alteration in either extreme favoring pathology
(Fig. 1).10. Redox signaling – the underlying pathways for redox
homeostasis, stress and adaptation
Every form of life is constantly exposed to a myriad of poten-
tially lethal stimuli. Therefore, cells, in order to survive, have to
deal with these challenges by activating a complex series of de-
fensive mechanisms. The acknowledged concertmaster organizing
the amplitude and duration of responses is the nuclear factor NF-
κB. For a comprehensive list of activators of NF-κB (physical,
chemical and biological) see [122]. Notably, NF-κB is activated by
oxidants (see above) but also produces, via activation of pro-in-
ﬂammatory cytokines, increases in NADPH oxidases [123,124],
inducible nitric oxide synthetase [125], and electrophiles that
decrease nucleophilic tone. The long lasting, poorly controlled or
inappropriate activation of NF-κB produces the series of patholo-
gical condition cumulatively referred to as inﬂammation-
dependent.
Nonetheless, feedback control of the NF-κB pathway results in
reestablishment of nucleophilic tone. Oxidants produced by the
NF-κB activated pro-inﬂammatory pathway increase Nrf2 activity,
which in turn increases nucleophilic tone. This feedback loop is
continuously active and responsible for much of redox home-
ostasis. Too long or too much of an upturn of NF-κB activity will
cause the production of more electrophiles than can be handled by
cellular homeostatic system.
Nucleophilic antioxidants are efﬁcient antagonist of the NF-κB
pathway and a myriad of botanical compounds sharing the che-
mical activity of “antioxidant” are listed as inhibitors of NF-κB
activity, activation or function [126]. However, the actual nucleo-
philic nature of these “antioxidants,” which are almost invariably
polyphenols, cannot directly supply the nucleophilic tone where
the actual nucleophiles are GSH and Trx, nor can they play any
reasonable physiological function by scavenging free radicals. The
actual fate of these “antioxidants” is their oxidation. A common
motif of these oxidized species is a α,β-unsaturated carbonyl, such
as the essential functional component of HNE. HNE and other α,β-
unsaturated aldehydes are among the most effective nucleophiles
for activation of Nrf2 [127].
In summary, the nutritional antioxidants mimic signaling by
endogenous electrophiles, including HNE. Indeed, studies of HNE
have evolved from being a cytotoxic lipid peroxidation product
[128] to a principal signaling electrophile in Nrf2 activation
[44,129]. The analysis of these events suggested a paradigm shift
in which an increase in electrophiles normally leads to restored
nucleophilic tone and only causes an offset from redox home-
ostasis when in excess. In principle, the redox pathways (pro-
duction of oxidants and feedback nucleophilic response) are in-
dispensable for healthy living and for maintaining redox home-
ostasis. An imbalance, even seemingly non-toxic, for too long can
lead to an adaptive stress response; i.e., a phenotypic shift to a
new homeostatic condition we often recognize as pathology.
11. Redox homeostasis, adaptation, hormesis andparahormesis
The broad concept of adaptation in biology, overlaps with the
more speciﬁc notion of hormesis in toxicology. An integrated
biological system (an organism or a cell) upon interaction with a
potentially damaging challenge, if not severely injured, may un-
dergo a phenotypic shift, acquiring resistance to the same or si-
milar stressor. Hormesis is, therefore, the term describing the
seemingly positive adaptive responses to minimal exposure to
agents that produce a well-deﬁned damage when the exposure is
higher. Adaptation operates through the stable activation of dif-
ferent mechanisms including repair. Thus adaptive mechanisms
establish a new homeostatic condition.
Prolonged exposure to a glucose concentration that is too low
results in ketosis, while prolonged exposure to too high glucose
results in depressed insulin sensitivity and diabetes. Such adap-
tations are positive as they contribute to prevent major damage
while keeping the organism going for a while, but are deﬁnitely far
from the normal physiological metabolic steady state and in-
trinsically harmful. The deviation from the physiological steady
state in adaptation probably depends more on the extent of the
stress than on the attempt to counter it.
Maintenance of redox homeostasis by feedback mechanisms
instead, is quite different from adaptation, but it ﬁts similar cri-
teria. Redox homeostasis refers to the endogenous capacity of cells
to continuously deal with challenges that generate electrophiles.
Challenges brought by different stressors are the result of meta-
bolic or environmentally non-injurious temporary movement to-
ward the edge of the normal physiological range. Maintenance of
redox homeostasis is achieved through feedback mechanisms
operating at different level of complexity such as relief of the in-
hibition of an enzyme [130] or transcriptional up-regulation
[131,132].
Parahormesis is the mechanism by which exogenous agents
(nutritional antioxidants) help maintain redox homeostasis by
restoring nucleophilic tone. This mechanism is at a ﬁrst glance a
paradox as the molecular mechanism of these antioxidants is
through oxidative alkylation of Keap1, the redox sensitive reg-
ulator of Nrf2. As described above, these molecules either have a
chemical functional group, such as an isothiocyanate or α,β-un-
saturated carbonyl, competent for Michael addition to sensitive
cysteine residues of Keap1, or are oxidized to a product that does
have such an electrophilic function. In terms of nutrition, these
compounds, typically from the vegetable kingdom, have the
function of contributing to the maintenance of the metabolic and
redox steady state, but they are not essential as are vitamins. Their
complementary function, to assist in maintaining redox home-
ostasis, becomes apparent only when a challenge exceeds the ca-
pacity of the endogenous nucleophilic feedback response (Fig. 1).12. Conclusions
Reversible redox transitions of proteins are the modiﬁable
elements of signal transduction pathways dynamically oscillating
from the oxidized and the reduced form. The homeostatic setting
depends upon the oxidation and reduction rates of independent
reactions; thus, the concept of dynamic equilibrium is less ap-
propriate than redox steady state. Kinetics controls the biological
efﬁciency of reactions in both directions. Therefore, the con-
centration of electrophiles, nucleophiles and the activity of the
enzymes catalyzing several of these reactions are the variable
elements of the redox steady state. Nucleophilic tone is transiently
depressed when the cell is challenged and it is feedback driven by
electrophiles. An inadequate feedback response is the emerging
cause of conditions where an excess of inﬂammatory reaction, or
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leads to the altered homeostasis we recognize as pathology.
The evidence discussed here mostly comes from studying how
pathological states evolve rather than how physiological redox
homeostasis is maintained. We urge investigators to focus more
effort on understanding the regulation of redox signaling during
homeostasis with the expectation that comparison will reveal
those redox signaling pathways that are the same in normal
physiology and pathology and those that are actually novel to
pathology. This could result in a greater rationale for focusing on
some redox signaling pathways as contributing more to disease
than others.
In terms of nutritional recommendations in the framework of
translational medicine we can conclude that supporting nucleo-
philic tone by nutritional compounds competent for facilitating
redox feedback (parahormetics) is the crucial nutraceutical func-
tion of these molecules. They are not as essential as vitamins, as
there is not a speciﬁc deﬁciency syndrome, nor are they drugs, as
there is not a speciﬁc effect suitable for quantitative evaluation;
however, they facilitate the maintenance of the “Golden Mean” by
helping maintain nucleophilic tone.Acknowledgments
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